Given the capacity of our ex vivo model of AD—based on cocultures of circulating memory T cells and autologous lesional epidermal cells—to generate translational insights by linking CLA+ T-cell cytokine production with patient clinical features (19–21), we used this system to investigate the IL-22 response. Here, IL22 is linked to Alzheimer disease.